Tonix Pharmaceuticals Holding Corp. company info

CIK 1430306
IRS Number 261434750
State of incorporation NV
Business address 509 MADISON AVE. - SUITE 1608
Mail address 509 MADISON AVE. - SUITE 1608

Short summary

Tonix Pharmaceuticals Holding Corp. is a New York company, with head office located at 509 Madison Ave. - Suite 1608 New York, New York 10022. In 2019 the company owned a total of 33.93 million USD worth of assets, including 33.40 million USD worth of current assets. 2014 was the year when the company amassed the most assets.

Tonix Pharmaceuticals Holding Corp. Income Statement

Name [in Millions USD]200820092010201120122013201420152016201720182019Trends
Research and development 0.581.162.584.6518.6235.5028.5313.3417.5618.19
Operating Expenses 1.933.386.6610.8927.6648.16
Operating Income (Loss) -1.93-3.38-6.66-10.89-27.66-48.16-38.97-21.29-26.32-28.83
Interest expense 0.00
Net income -0.20-0.22-1.96-3.47-9.45-10.88-27.62-48.05-38.84-21.12-26.09-28.62

Tonix Pharmaceuticals Holding Corp. Balance Sheet

Name [in Millions USD]200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents 1.7943.8748.7414.9434.3616.6812.1530.67
Available-for-sale Securities, Current 16.31
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Available-for-sale Securities, Noncurrent
Intangible Assets, Net (Excluding Goodwill)
Total assets 0.001.530.3145.0750.9334.3235.8218.3615.0133.93
Current assets 0.091.410.1144.8250.3133.6635.4918.1614.1633.40
Accounts payable 0.320.491.461.522.771.941.181.641.041.41
Total current liabilities 0.340.782.262.374.624.201.832.512.052.66
Total liabilities 0.010.812.282.404.684.281.852.512.192.69
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -37.94-75.79-126.18-151.08-175.39-200.53-224.34
Accumulated Other Comprehensive Income (Loss), Net of Tax

Tonix Pharmaceuticals Holding Corp. Cash Flow

Name [in Millions USD]200820092010201120122013201420152016201720182019Trends
Net income -0.20-0.22-1.96-3.47-9.45-10.88-27.62-48.05-38.84-21.12-26.09-28.62
Depreciation and amortization
Depreciation and amortization
Net Cash Provided by (Used in) Operating Activities -1.23-2.64-5.71-37.31-19.13-23.97-26.68
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Intangible Assets 000.12
Net Cash Provided by (Used in) Investing Activities -0.090.00-0.0416.557.17-0.01-0.02
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.04-0.02-0.39-24.1716.59
Proceeds from Issuance of Common Stock 1.3406.9310.0447.8447.6920.5018.5112.715.87
Net Cash Provided by (Used in) Financing Activities 1.392.617.4920.5018.5223.5412.92
Cash and Cash Equivalents, Period Increase (Decrease) 6.4229.98-19.01-0.236.56